Genetic mutations such as BRCA1 convey dramatically increased risks of triple-negative breast cancer [45,46], and the results of genome-wide association studies may eventually guide even more personalized risk prediction [47,48]. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.